期刊文献+

抵抗素与稳定性冠心病病死率的相关性研究 被引量:3

Correlation between resistin and mortality of stable coronary heart disease
下载PDF
导出
摘要 目的研究血清抵抗素水平与稳定性冠心病患者病死率的相关性。方法选择医院确诊的稳定性冠心病患者320例,采用酶联免疫吸附法(ELISA)检测其血清抵抗素水平,按血清抵抗素水平将患者分为4组:1组(<5.78 ng/ml)、2组(5.79~8.51 ng/ml)、3组(8.52~12.21 ng/ml)和4组(>12.21 ng/ml),分析各组抵抗素水平与临床特征及3年全因死亡率的相关性。结果116例(36.5%)患者随访期间因心肌梗死和心衰入院治疗;组死亡例数分别为3例(4.0%)、6例(7.2%)、6例(7.8%)、11例(12.9%),患者死亡率随抵抗素水平升高而升高(P<0.01),其中4组病死率显著高于1组(P<0.05);Cox回归分析显示,血清抵抗素水平越高,患者全因病死率和心衰及其心血管事件风险也越高。结论抵抗素水平与稳定性冠心病患者全因病死率相关,可作为预测该病患者心血管事件不良结局的评价指标。
出处 《西南国防医药》 CAS 2018年第6期563-565,共3页 Medical Journal of National Defending Forces in Southwest China
  • 相关文献

参考文献5

二级参考文献50

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2049
  • 2STEPPAN CM, BAILEY ST, BHAT S, et al. The hormone re- sistin links obesity diabetes [J]. Natu~, 2001, 409 (6818): 307-312.
  • 3STEPPAN CM, BROWN EJ, WRIGHT CM, et al. A family of tissue-specific resistin 2 like molecules [J]. Proc Natl Acad Sci USA, 2001, 16: 502-506.
  • 4ROSENBAUM M, NONAS C, HORLICK M, et al. Beta-Cellfunct ion and insulin sensitivity in early ado lescence: association with body fatness and family history of type 2 diabetes mellitus[J]. Clin Endocrinol Metab, 2004, 89(11): 5469-5476.
  • 5YANNAKOULIA M, YANNAKOURIS N, BLUHER S, et al. Body fat mass and maecronutrient intake in relation to circulat- ing soluble eptin receptor, free leptin index, adiponeetin, and resistin concent rations in healthy humans[J]. J Clin Endccrinol Metab, 2003, 88: 1730-1736.
  • 6Fihn SD, Gardin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J].Circulation, 2012,126:e354-e471.
  • 7Fihn SD, Gardin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J].Circulation, 2012,126:3097-3137.
  • 8Task force members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology[J].Eur Heart J, 2013,34:2949-3003.
  • 9Qaseem A, Fihn SD, Williams S, et al.Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons[J].Ann Intern Med 2012;157:729-734.
  • 10QIAO Xiao-zhi YANG Yun-mei XU Zhe-rong YANG Li-ai.Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2007,8(12):875-880. 被引量:12

共引文献235

同被引文献14

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部